00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Eli Lilly's newly launched obesity pill recorded 1,390 U.S. prescriptions in the week,
00:08ended April 10th, according to Reuters.
00:11Novo Nordisk's Oral Wegevy reached 3,071 prescriptions in its first four days after
00:17its January 5th launch and totaled 113,354 prescriptions in the same week, up from 105,366
00:26the prior week.
00:29Fondeo received approval on April 1st, with prescriptions accepted immediately and shipping
00:33starting April 6th, followed by broader U.S. availability on April 9th.
00:38Guggenheim analysts said Lilly expects volatility in early prescription data due to varying capture
00:43rates.
00:44Shares of Eli Lilly rose nearly 3% in pre-market trading.
00:48The company did not immediately respond to Reuters' request for comment.
00:52For all things money, visit Benzinga.com.
Comments